After Wyeth's Pristiq took a long, rocky road to approval, the company's trying to smooth the antidepressant's path to doctors' prescription pads with a cut-rate price. Wyeth Headquarters (Mike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results